Regulation & policy

NI+FSSAI enforces labeling rules for coffee, neem and other plant nutraceuticals

The Food Safety and Standards Authority of India (FSSAI) is enforcing labeling requirements for nutraceuticals containing certain botanicals and plant parts, including coffee, neem and Coleus forskohlii, amid cases of non-compliance.

FDA reexamining dietary substance definition as industry seeks clarity on novel ingredients

FDA is taking another look at how it interprets the statutory definition of a dietary substance, a move that could have implications for novel ingredients seeking a path to market, according to Cara Welch, PhD, director of the agency’s Office of Dietary...

What Health Canada’s resveratrol and beta-glucan updates mean for manufacturers

Before the revisions, companies using fermentation-derived bioactives could face additional requests for evidence about their ingredient sources or production methods, even when the intended use was already covered by Health Canada’s pre-cleared information.

NI+EU reverses novel food decision on healthy aging ingredient SAMe

The European Commission has revised the novel food status of S-adenosyl-L-methionine (SAMe) disulfate tosylate, recognizing the ingredient as non-novel for use in food supplements.

NI+NDI notifications: FDA releases final guidance on identity and safety

The U.S. Food and Drug Administration has released a final guidance on recommendations around the information required to demonstrate the identity and the safety of a new dietary ingredient (NDI).

Across the Nutraverse: Accelerating EU novel foods, NZ explores natural health product rule changes, closing GRAS oversight gaps

This week’s brief tracks news that highlights the strategic importance of scientific substantiation, safety data, and regulatory readiness as increasingly important competitive advantages.

Brand new: Andrographis reformulation, PDRN innovation, biotics for eczema

See new developments from health and nutrition brands across Asia-Pacific, including Australian brands recalling and reformulating their Andrographis products due to regulatory changes, and the use of PDRN in oral supplements and biotics for eczema.

NutraCast: Supplement companies should act on patents early to protect innovation

Dietary supplement companies should consider intellectual property protection early in product development to safeguard innovation and reduce risk of infringing existing patents, according to Peter Paredes and George Carrera, Jr. of Amin, Wasserman and...

NI+FDA cites GRAS oversight gaps in push for mandatory notifications, requests comments

During a webinar on Thursday, U.S. Food and Drug Administration officials reiterated that updates to its generally recognized as safe (GRAS) rule would give the agency and the public a clearer picture of substances entering the food supply while...

EU platform launched to accelerate novel food approvals

The Ministry of Future Affairs has launched a new platform to help companies navigate the EU’s novel food approval process and reduce delays, drawing on lessons from the UK’s regulatory sandbox for cultivated meat.

NI+US court shuts down fraudulent Timeline copycat websites

Swiss health sciences company Timeline secured a court order from the U.S. District Court for the District of Massachusetts targeting a network of websites that impersonated its official website, timeline.com, to sell counterfeit or non-existent Mitopure...

NI+New Zealand considering changes to natural health product rules

The New Zealand government is seeking public feedback on proposed requirements for natural health products, including how health claims may be permitted and regulations for pre-market entry, manufacturing and labeling requirements.

CRN seeks regulatory clarity on drug preclusion, self-GRAS and supplement innovation

The Council for Responsible Nutrition (CRN) is pursuing regulatory changes to improve certainly for supplement companies, from drug preclusion and ingredient grandfathering to the future of self-affirmed GRAS, said president and CEO Steve Mister.

NI+Supplement sector rising, ‘safety needs to evolve with it’

Growing supplement use, novel ingredients, personalized nutrition and digital health advice are challenging safety frameworks in a fragmented global regulatory landscape, prompting greater discussion about the tools needed to foster regulatory coherence.

NI+Brands begin andrographis recalls, product reformulation in Australia

Brands in Australia have begun voluntarily recalling listed medicines containing andrographis following a ban issued by the Therapeutic Goods Administration (TGA) last month over concerns that the herb may trigger anaphylactic reactions.

FDA, industry outline priorities for dietary supplement modernization

As the US Food and Drug Administration (FDA) considers how to modernize dietary supplement oversight, Cara Welch, PhD, director of FDA’s Office of Dietary Supplement Programs, has emphasized the agency’s commitment to keeping pace with an evolving...

Across the Nutraverse: Dutch botanical restrictions, British supplement ads, precision fermentation, omega-3s move beyond fish oil, and HTBA buys Specnova

This week’s brief tracks news that highlights the stricter compliance requirements and stronger technology-based differentiation.

Regulatory review: USFDA’s gummy study, Australia’s rules on andrographis and more

The U.S. Food and Drug Administration’s (USFDA) assessment of gummy supplements production, Australia’s stricter rules on andrographis use and New Zealand’s upcoming revisions to its natural health products export policies are some of the latest updates...

NI+Sticky situation: FDA weighs in on gummy dietary supplements

The U.S. Food and Drug Administration has been keeping an eye on functional gummies, concerned that the popular dietary supplement format may not always be delivering what it says it is.

NI+EFSA sets out scientific priorities for food safety, innovation and AI

The European Food Safety Authority (EFSA) has published a roadmap for European food regulation over the next decade, outlining how food safety risk assessments should evolve in response to innovation, climate change and emerging technologies.

NI+Proposed Dutch supplement rule changes could force product reformulation

The Netherlands has proposed new restrictions on some plants and substances used in herbal preparations and food supplements, with the draft legislation open for consultation until Dec. 7, 2026.

Opinion piece

Drug Preclusion: Necessary Reform

Industry agrees that drug preclusion is broken and in need of reform. We all saw what happened with NAC and NMN. And we want dietary supplement companies to have greater certainty before investing millions of dollars developing and marketing an ingredient.

NI+Thousands of supplement ads at risk of non-compliance, ASA investigation finds

Ads for wellness products and supplements often breach advertising regulations, according to a new, large-scale analysis by the Advertising Standards Agency (ASA).

NutraCast: Beyond the COA – Testing blind spots put brands at risk

As retailers and regulators demand greater confidence in product quality, brands are taking a closer look at what their testing actually proves.

Opinion piece

Drug preclusion: Consider the source

CRN, CHPA and AHPA are celebrating H.R. 10336 as a balanced compromise. But in the pursuit of regulatory certainty, has part of the supplement industry agreed to permanently enshrine the very pharmaceutical gatekeeping mechanism it has spent years fighting?

NI+Botanical safety: Is Article 8 fit for purpose?

In the European Union, Article 8 procedures are used to evaluate, restrict and remove potentially unsafe ingredients from the supplement market, but its use in recent years has been the subject of controversy.

NI+Botanical Safety Consortium: Tools needed to decode the ‘most creative synthetic factories’

Botanicals are complex mixtures of chemical compounds with potent pharmacological and toxicological properties. They have been used for centuries as both food and medicine for therapeutic benefits but can also present safety risks.

NI+California signs restrictive supplement bill into law, industry concerned

California Governor Gavin Newsom has signed AB 2030 into law, imposing new age restrictions on a broad array of dietary supplements marketed or represented for weight loss or muscle building as part the state’s holistic healthcare strategy.

SANS USA moves to Dallas for 2027

The Sports & Active Nutrition Summit USA (SANS USA) is heading to Dallas in 2027 after two consecutive sold-out editions in San Diego.

ASA calls out health claim breaches as food brands become function focused

Food brands’ increasing use of health and nutrition messaging reflects a broader trend of ‘aggressive marketing’ across the UK, a legal expert has warned after the ASA called out Whitworths Ltd for claiming nuts could extend life and reduce the risk of...

Across the Nutraverse: NZ claims for exports, Amway vs FTC, Bio-K+ in the UK, Better Menopause, krill oil pulled from Aus retailers

This week’s brief tracks news that highlights the industry’s shift towards a future defined by stronger regulatory oversight, greater scientific substantiation, export-focused regulatory reform, and growing sustainability expectations.    

Alice Mushrooms case tests limits of ingredient substantiation

A recent case decision offers a closer look at how the National Advertising Division (NAD) approaches ingredient-level research when companies make claims for multi-ingredient products, including when that evidence can be extrapolated to the finished...

NutraIngredients at 25

NutraCast: NutraIngredients at 25 | Stephen Daniells reflects on two decades of change

As NutraIngredients celebrates 25 years, Global Editor-in-Chief Stephen Daniells, PhD, looks back at the 20+ years he has been with the publication. From the early days of digital publishing to the rise of social media, podcasts, video and now AI,...

New Jersey legislator introduces restrictive supplements bill

A lawmaker in New Jersey has filed a bill to prohibit the sale of weight loss and muscle building products to minors, part of a broader trend of state-level efforts to restrict youth access to certain dietary supplements.

NI+Kiwi government proposes new rules for supplement exports, industry voices support

New Zealand’s Food Safety Minister Andrew Hoggard has proposed loosening requirements for dietary supplements meant for export—a move that the local industry believes would be a game-changer.

Amway agrees $225 million settlement with FTC over alleged deceptive business practices

Multilevel marketing giant Amway and two Amway licensees will pay $225 million to resolve allegations from the Federal Trade Commission and the state of Washington for alleged unfair and deceptive tactics.

What is the industry getting wrong? FNIS leaders weigh in

From social media pseudoscience and influencer culture to industry advocacy and trend-chasing, Future Nutra Innovation Summit (FNIS) attendees outlined where they see gaps — and what could change them.

Regulatory update

NI+Brazil authorizes new supplement ingredients and health claims

Brazil’s National Health Surveillance Agency (ANVISA) has updated its regulatory framework for dietary supplements, adding new authorized ingredients, establishing dosage limits and introducing new health claims that manufacturers can use on supplement...

NI+Industry, research experts surprised, disappointed at TGA’s Andrographis removal

Australia’s health supplement and herbalist associations, along with a leading botanical research expert, have voiced disappointment over the Therapeutic Goods Administration’s (TGA) decision to remove Andrographis from listed medicines, asking why...

NI+‘Turning point’ for CBD as EFSA publishes first positive safety opinion

The European Food Safety Authority (EFSA) has published its first positive safety opinion for a CBD novel food application, marking a turning point for the industry, but concerns remain over the commercial viability of its imposed low daily limit.

Nestlé Russia under state control: What happens next?

As the dust settles on Russia’s takeover of Nestlé’s local operations, analysts warn the move could reshape how multinationals assess risk in the country

NI+UK food industry must band together to protect the health of the nation, experts say

With 9 million UK citizens heading for chronic disease by 2040, health has become a central focus for consumers, with 89% of households now prioritizing health and well-being, according to data from NielsenIQ (NIQ).

Andrographis no longer allowed in new listed medicines sold in Australia

Andrographis paniculata is no longer allowed in new listed medicines sold in Australia, starting from Sept. 17, 2026, the local regulator, the Therapeutic Goods Administration (TGA), announced. Sponsors of existing Andrographis products will be receiving...

What will define the next era of nutra? Industry leaders weigh in at FNIS

The next five years of nutraceutical innovation could be defined less by a single breakthrough ingredient and more by the convergence of technology, nature, new delivery formats and changing consumer behavior, according to industry leaders at the Future...

NI+Botanical adulteration on the rise despite 15 years of industry action

Adulteration is one of the most significant and persistent issues facing the botanical industry, and the issue appears to be on the rise, exacerbated by supply chain pressures, trade wars and climate change.

NI+FSA signals ‘major milestone’ in CBD novel food process: Should industry raise its hopes?

The UK Food Standards Agency (FSA) has described its recommendation to authorize the country’s first CBD novel food applications as a “major milestone”, but industry observers question whether the move marks a genuine regulatory breakthrough or simply...

NI+New bill seeks to fix drug preclusion provision to boost dietary supplement innovation

Congresswoman Diana Harshbarger (R-TN) introduced the Dietary Supplement Innovation Act with the aim of modernizing the Food and Drug Administration’s (FDA) drug preclusion provision, a move that has been welcomed by dietary supplement trade associations.

NI+Gnosis secures EFSA approval for novel glutathione form

EFSA has published a positive safety opinion on S-acetyl glutathione (SAG), a chemically modified version of glutathione designed to enhance bioavailability.

Regulatory review: Ingredients safety re-evaluation, NMN product naming and more

South Korea’s Ministry of Food and Drug Safety’s (MFDS) re-evaluation of functional ingredients such as bilberry extract and Australia’s Therapeutic Goods Administration’s (TGA) guidance on NMN product naming are some of the latest updates in this...

NI+Luxembourg introduces new MPLs for vitamins and minerals in supplements

Luxembourg has updated its food supplement regulations, setting new maximum permitted limits (MPLs) for certain vitamins and minerals used in food supplements.